
The article details two options strategies for AstraZeneca (AZN), currently trading at $73.52, to optimize investor positioning. Selling a cash-secured put at the $71.00 strike offers a potential 3.19% annualized yield if it expires worthless (67% probability) or a $70.69 cost basis if assigned, representing a 3% discount. Concurrently, a covered call at the $77.00 strike provides a potential 5.41% return by September 26th if called away, or a 4.96% annualized yield boost if it expires worthless (63% probability), illustrating methods to enhance yield or acquire shares at a discount.
The options market for AstraZeneca (AZN), currently trading at $73.52, presents specific strategies for income generation and discounted share acquisition. Selling a cash-secured put at the $71.00 strike price for a 31-cent premium establishes an effective cost basis of $70.69, a roughly 3% discount to the current market price, should the shares be assigned. Probabilistic models suggest a 67% chance of this out-of-the-money put expiring worthless, which would result in a 3.19% annualized yield on the cash commitment. For existing shareholders, a covered call strategy at the $77.00 strike offers a 50-cent premium. This caps the potential gain but provides a total return of 5.41% if called away by the September 26th expiration. The probability of this call expiring worthless is 63%, in which case the premium enhances returns by an annualized 4.96%. Critically, the implied volatility of approximately 28% for these contracts is slightly elevated compared to the 25% trailing twelve-month historical volatility, suggesting a modest premium is being priced in for option sellers.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.35
Ticker Sentiment